In a world obsessed with invasive biopsies and expensive imaging, Oncoustics is betting big on the physics of sound. They're not building another app—they're engineering ultrasound transducers to listen to the liver's cellular whispers, aiming to detect fibrosis non-invasively and at a fraction of the cost of an MRI.

"They aren't just selling software; they are selling a new way to 'hear' disease, turning ultrasound from a visual tool into a diagnostic microphone."

The traffic data paints a fascinating picture of a 'stealth' B2B giant. While their global rank is #3.1M—seemingly low—the keyword strategy is surgical. They own the search for 'Velacure Fibroscan' (360 volume) and 'Mohamed Ibrahim Ahmed Stanford' (230 volume). This indicates a strategy focused on specific IP, proprietary technology names, and key personnel thought leadership rather than broad consumer awareness.

• High-Value Efficiency: $245K revenue per employee indicates a highly scalable operational model.
• Niche SEO Dominance: They rank for specific, high-intent medical and personnel keywords, not generic terms.
• Acoustic AI Focus: The tech stack (AWS CloudFront, jQuery) supports a data-heavy, cloud-based diagnostic platform.
• Clinical-First Leadership: The executive team blends medical operations with machine learning expertise.